BLI
NASDAQBerkeley Lights Inc.
Latest news
25 items- PRContineum Therapeutics Announces Appointment of Sarah Boyce to Board of DirectorsContineum Therapeutics, Inc. (NASDAQ:CTNM), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced the appointment of Sarah Boyce, President and Chief Executive Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), as an independent member of its Board of Directors. Ms. Boyce brings over 25 years of global commercial and clinical development expertise in the life sciences industry to Contineum's board. Ms. Boyce has extensive expertise in global pharmaceut
- 13D/GSEC Form SC 13G/A filed by Berkeley Lights Inc. (Amendment)SC 13G/A - Bruker Cellular Analysis, Inc. (0001689657) (Subject)
- SECSEC Form 15-12G filed by Berkeley Lights Inc.15-12G - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- INSIDERKadia Siddhartha returned 1,240,689 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERChiminski John R returned 112,465 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERSilvester Peter returned 64,596 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERHopfield Jessica returned 105,207 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERJoshi Mehul returned 65,013 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERHobbs Eric returned 244,816 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERMoritz Michael J returned 1,451,925 shares to the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERLucier Gregory T returned 136,062 shares to the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERNelson Elizabeth A returned 75,965 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERRothman James returned 118,810 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERKhandros Igor Y returned 8,819,993 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERBruker Corp acquired $99,711,327 worth of shares (1,000 units at $99,711.33) (SEC Form 4)4 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- INSIDERNew insider Bruker Corp claimed ownership of 81,254,441 shares (SEC Form 3)3 - Bruker Cellular Analysis, Inc. (0001689657) (Issuer)
- SECSEC Form POSASR filed by Berkeley Lights Inc.POSASR - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- SECSEC Form S-8 POS filed by Berkeley Lights Inc.S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- SECSEC Form S-8 POS filed by Berkeley Lights Inc.S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- SECSEC Form S-8 POS filed by Berkeley Lights Inc.S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- SECSEC Form S-8 POS filed by Berkeley Lights Inc.S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- SECSEC Form S-8 POS filed by Berkeley Lights Inc.S-8 POS - Bruker Cellular Analysis, Inc. (0001689657) (Filer)
- SECSEC Form 25-NSE filed by Berkeley Lights Inc.25-NSE - Bruker Cellular Analysis, Inc. (0001689657) (Subject)
- SECBerkeley Lights Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders8-K - PhenomeX Inc. (0001689657) (Filer)
- SECSEC Form SC TO-T/A filed by Berkeley Lights Inc. (Amendment)SC TO-T/A - PhenomeX Inc. (0001689657) (Subject)
BLI FAQ
7 questionsWhat does Berkeley Lights Inc. do?
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. The company was incorporated in 2011 and is headquartered in Emeryville, California.Where does BLI stock trade?
Berkeley Lights Inc. (BLI) is listed on NASDAQ.What sector and industry is BLI in?
Berkeley Lights Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.When did Berkeley Lights Inc. go public?
Berkeley Lights Inc. (BLI) completed its IPO in 2020.What are analysts saying about BLI?
Berkeley Lights Inc. has had 8 recent analyst actions on file. The most recent action was from Morgan Stanley: Underweight with a $500.00 price target on 2022-08-10. Recent price targets range from $500.00 to $2000.00.What companies are similar to BLI?
Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), RGC (Regencell Bioscience Holdings Limited), RLX (RLX Technology Inc.). Compare BLI side-by-side with any of them on Quantisnow.How can I track BLI on Quantisnow?
Quantisnow aggregates Berkeley Lights Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BLI to receive live email and push alerts on every new disclosure.